Synthesis, Structures and Antimicrobial Activities of Novel Schiff Base Ligand and Its Metal Complexes

被引:2
作者
Adhao, Sopan Tejrao [1 ]
Wagh, Rahul Ramchandra [1 ]
机构
[1] Patkar Varde Coll, Dept Chem, Mumbai 400104, Maharashtra, India
关键词
Ligand; Complexes; Spectroscopy; Thermogravimetry; Broth Dilution Method; COUMARIN DERIVATIVES;
D O I
10.13005/ojc/390617
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel ligand (E)-7-hydroxy-4-methyl-8-(1-(naphthalen-1-ylimino) ethyl)-2H-chromen-2-one [HOMNIEC] was synthesized by condensation of 8-acetyl-7-hydroxy-4-methyl-2H-chromen-2-one and Naphthalen-1-amine by the reported method. The metal complexes with this ligand were synthesized by using a common new method. FTIR, 1H NMR, Mass Spectrometry and TGA techniques were used to confirm their structures. The FTIR spectral data indicate that the ligand was coordinated with the metal ions through the phenolic oxygen on coumarin moiety and nitrogen of azomethine. The ligand and complexes were examined for in vitro antimicrobial activities using broth microdilution method in DMSO medium against Escherichia coli (MTCC 443) and Pseudomonas aeruginosa (MTCC 1688) a Gram-negative bacterial strain, Staphylococcus aureus (MTCC 96) and Streptococcus pyogenes (MTCC 442) a Gram-positive bacterial strain, and Candida albicans (MTCC 227), Aspergillus clavatus (MTCC 1323) and Aspergillus niger (MTCC 280) fungal strains. The metal complexes were found to have enhanced antimicrobial activities compare to the Schiff base [HOMNIEC] ligand. Especially, the antifungal activity of Cu(II) and Zn(II) ions complexes was found to be twofold more than the standard drug griseofulvin against C. albicans.
引用
收藏
页码:1571 / 1578
页数:8
相关论文
共 23 条
[1]   Synthesis and photoluminescent properties of a Schiff-base ligand and its mononuclear Zn(II), Cd(II), Cu(II), Ni(II) and Pd(II) metal complexes [J].
Aazam, E. S. ;
El Husseiny, A. F. ;
Al-Amri, H. M. .
ARABIAN JOURNAL OF CHEMISTRY, 2012, 5 (01) :45-53
[2]  
Aazam ElhamS., 2010, JKAU: Set, V22, P101
[3]  
Albert B., 1991, Manual of Clinical Microbiology, V5th, P1173
[4]  
Anantha Lakshmi P. V., 2010, Int. J. of Pharma. and Pharma. Sci., V2, P150
[5]  
Furniss B.S., 1989, VOGELS TXB PRACTICAL, V4th
[6]  
Ingle V. S., 2023, Asi. J. of Chem., V35, P327, DOI [10.14233/ajchem.2023.24036, DOI 10.14233/AJCHEM.2023.24036]
[7]  
Isenberg H.D., 2004, Clinical Microbiology Procedures Handbook, V2
[8]  
Jeffery G.H., 1989, VOGELS TXB QUANTITAT
[9]  
Khanum S. A., 2019, Science Direct, Biomed. & Pharma., V112, P1
[10]  
Mevlut B., 2008, Acta Chim. Slov, V55, P120